RxDoctor Payments DataLook up a doctor →

Anne Feaster

Adult Health · Langhorne, PANPI 1932259652

Payments from drug & device makers

$15,197in general payments, 2019–2025

Across 633 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Novartis$1K
  • Daiichi Sankyo Inc.$728
  • Incyte Corporation$627
  • AstraZeneca$613
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)51$1,442
E.r. Squibb & Sons, L.L.C.32$1,079
Novartis47$1,004
Daiichi Sankyo Inc.29$728
Incyte Corporation32$627
AstraZeneca(2 entities)28$613
Merck25$584
Gilead(2 entities)17$532
Astellas Pharma US Inc17$498
Amgen15$444
Pfizer27$420
Eisai Inc.19$405
AbbVie19$393
Pharmacyclics LLC, An Abbvie Company15$357
Takeda Pharmaceuticals U.S.A., Inc.11$355
Genmab U.S., Inc.10$335
Karyopharm Therapeutics Inc.8$318
Genentech USA, Inc.16$312
Seagen Inc.14$303
Bayer13$284
Bristol Myers Squibb13$282
GSK13$276
Lilly USA, LLC10$256
EMD Serono, Inc.5$222
Regeneron Healthcare Solutions, Inc.10$207
Array Biopharma Inc12$196
Sanofi7$192
Puma Biotechnology, Inc.8$173
Morphosys, US Inc.8$171
Stemline Therapeutics Inc.7$152
Pharmacosmos Therapeutics Inc.7$140
Myovant Sciences Inc.6$137
Blueprint Medicines Corporation4$129
Acrotech Biopharma Inc.6$121
Tersera Therapeutics LLC4$104
Exelixis Inc.4$98
Rigel Pharmaceuticals, Inc.6$94
Beone Medicines USA, Inc.3$85
Sobi, Inc4$83
Mirati Therapeutics, Inc.4$75
Boehringer Ingelheim3$73
Apellis Pharmaceuticals, Inc.3$69
Mylan Institutional Inc.3$68
Ipsen Biopharmaceuticals, Inc3$67
G1 Therapeutics, Inc.3$66
Myriad Genetic Laboratories, Inc.3$65
Taiho Oncology, Inc.4$59
Sumitomo Pharma America, Inc.2$49
Jazz Pharmaceuticals Inc.2$47
Pharmaessentia USA Corporation2$41
AVEO Pharmaceuticals, Inc.2$38
Foundation Medicine, Inc.2$38
Recordati_rare_diseases_inc.2$34
Organon1$32
Immunogen, Inc.1$29
ADC Therapeutics America, Inc.2$25
Kyowa Kirin, Inc.1$25
Iovance Biotherapeutics, Inc.1$24
CSL Behring1$21
Beigene USA, Inc.1$19

How this compares

$15,197 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$22,253
Medicare patients
139
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Langhorne

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →